Literature DB >> 17192061

Microsatellite instability in the development of DNA mismatch repair deficient tumors.

Stefan M Woerner1, Matthias Kloor, Magnus von Knebel Doeberitz, Johannes F Gebert.   

Abstract

Microsatellites are highly abundant short repetitive sequences found in the genomes across different species. They have gained increasing interest in recent years because length alterations in several coding as well as non-coding microsatellites are associated with a variety of different disorders. Particularly, microsatellite mutations play an important role in tumorigenesis of DNA mismatch repair deficient tumors that account for up to a 15% of colorectal, endometrial, and various other cancers. The systematic analysis of the distribution and function of affected microsatellite sequences has facilitated to unravel important steps in the selection processes that drive tumorigenesis. Here, we review the role of microsatellite mutations in the development of cancers with DNA mismatch repair deficiency, outlining biostatistical approaches for the identification of MSI target genes with relevance to MSI associated carcinogenesis. Knowledge about the biological impact of microsatellite mutations in these genes will potentially help to develop modified clinical concepts for diagnosis, prevention, and treatment of microsatellite unstable human cancers.

Entities:  

Mesh:

Year:  2006        PMID: 17192061     DOI: 10.3233/cbm-2006-21-208

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  28 in total

1.  Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer.

Authors:  Kai Wang; Junsuo Kan; Siu Tsan Yuen; Stephanie T Shi; Kent Man Chu; Simon Law; Tsun Leung Chan; Zhengyan Kan; Annie S Y Chan; Wai Yin Tsui; Siu Po Lee; Siu Lun Ho; Anthony K W Chan; Grace H W Cheng; Peter C Roberts; Paul A Rejto; Neil W Gibson; David J Pocalyko; Mao Mao; Jiangchun Xu; Suet Yi Leung
Journal:  Nat Genet       Date:  2011-10-30       Impact factor: 38.330

2.  Coding Microsatellite Frameshift Mutations Accumulate in Atherosclerotic Carotid Artery Lesions: Evaluation of 26 Cases and Literature Review.

Authors:  Carolin Kurz; Maani Hakimi; Matthias Kloor; Caspar Grond-Ginsbach; Marie-Luise Gross-Weissmann; Dittmar Böckler; Magnus von Knebel Doeberitz; Susanne Dihlmann
Journal:  Mol Med       Date:  2015-06-09       Impact factor: 6.354

3.  CTNNB1-mutant colorectal carcinomas with immediate invasive growth: a model of interval cancers in Lynch syndrome.

Authors:  Aysel Ahadova; Magnus von Knebel Doeberitz; Hendrik Bläker; Matthias Kloor
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

4.  Analysis of microsatellite instability in medulloblastoma.

Authors:  Marta Viana-Pereira; Inês Almeida; Sónia Sousa; Bethânia Mahler-Araújo; Raquel Seruca; José Pimentel; Rui Manuel Reis
Journal:  Neuro Oncol       Date:  2009-01-29       Impact factor: 12.300

5.  Lack of HLA class II antigen expression in microsatellite unstable colorectal carcinomas is caused by mutations in HLA class II regulatory genes.

Authors:  Sara Michel; Michael Linnebacher; Joshua Alcaniz; Maike Voss; Rudolf Wagner; Wolfgang Dippold; Christina Becker; Magnus von Knebel Doeberitz; Soldano Ferrone; Matthias Kloor
Journal:  Int J Cancer       Date:  2010-08-15       Impact factor: 7.396

6.  Serum antibodies against frameshift peptides in microsatellite unstable colorectal cancer patients with Lynch syndrome.

Authors:  Miriam Reuschenbach; Matthias Kloor; Monika Morak; Nicolas Wentzensen; Anja Germann; Yvette Garbe; Mirjam Tariverdian; Peter Findeisen; Michael Neumaier; Elke Holinski-Feder; Magnus von Knebel Doeberitz
Journal:  Fam Cancer       Date:  2010-06       Impact factor: 2.375

7.  Conservation of human microsatellites across 450 million years of evolution.

Authors:  Emmanuel Buschiazzo; Neil J Gemmell
Journal:  Genome Biol Evol       Date:  2010-02-08       Impact factor: 3.416

Review 8.  Defective mismatch repair, microsatellite mutation bias, and variability in clinical cancer phenotypes.

Authors:  Sandeep N Shah; Suzanne E Hile; Kristin A Eckert
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

Review 9.  Towards a vaccine to prevent cancer in Lynch syndrome patients.

Authors:  Magnus von Knebel Doeberitz; Matthias Kloor
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

10.  Fas ligand expression in lynch syndrome-associated colorectal tumours.

Authors:  Jan J Koornstra; Steven de Jong; Wietske Boersma-van Eck; Nynke Zwart; Harry Hollema; Elisabeth G E de Vries; Jan H Kleibeuker
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.